IP Library Granted Patent US 6,861,513
Granted Patent B2
US 6,861,513 · App. 09/758,759 · Granted Mar 1, 2005

Everninomicin biosynthetic genes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,861,513
App. No.
09/758,759
Granted
Mar 1, 2005
Kind
B2
Abstract

This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin everninomicin and to use of the nucleic acids and proteins to produce compounds exhibiting antibiotic activity based on the everninomycin structure. The DNA sequence for the gene clusters responsible for encoding everninomicin biosynthetic genes, which provide the machinery for producing everninomicin, are provided. Thus, this invention provides the nucleic acid sequences needed to synthesize novel everninomicin-related compounds based on everninomicin, arising from modifications of the DNA sequence designed to change glycosyl and modified orsellinic acid groups contained in everninomicin. A. Micromonospora site-specific integrase gene is also provided, which can be incorporated in a vector for integration into any actinomycete, and, particularly into Monospora . Thus, the invention further provides methods for introducing heterologous genes into an actinomycete chromosome using this particular vector.

Claims (12)

1. An isolated nucleic acid comprising the nucleotide sequence of SEQ ID NO:1.

2. A vector comprising a nucleic acid of claim 1 .

3. A host comprising a vector of claim 2 .

4. A host cell of claim 3 , which is a bacterial host cell.

5. A host cell of claim 4 , which is an E. coli or an actinomycete.

6. A host cell of claim 5 , which is Streptomyces or Micrornonospora.

7. A method for expressing an everninomicin biosynthetic pathway gene product from a Micromonospora carbonacoa , comprising culturing a host cell of claim 6 under conditions that permit expression of the everninomicin biosynthetic pathway gene product.

8. A method for selecting for growth of a host cell comprising an everninomycin-resistant growth phebotype, comprising growing a host cell containing the vector of claim 2 in the presence of an amount of everninomicin that is toxic to a host cell which does not contain the vector.

9. A vector for genetic integration in an actinomycete host cell comprising the nucleic acid of claim 1 .

10. A vector of claim 9 , further comprising a heterologous gene.

11. A method for introducing a heterologous gene into an actinomycete, comprising introducing the vector of claim 10 into the actinomycete.

12. The method according to claim 11 , wherein the actinomycete is of the genus Micromonospora.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →